Upadacitinib Delivers Durable 1-Year Benefits in Real-World UC

By News Health
2 hours Ago

(MedPage Today) — LAS VEGAS — Upadacitinib (Rinvoq) demonstrated durable clinical, endoscopic, and histologic benefit in a large real-world cohort of patients with ulcerative colitis (UC), with many maintaining remission over time and others…

Source link : https://www.medpagetoday.com/meetingcoverage/ccc/119587

Author :

Publish date : 2026-01-26 18:03:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Focus Groups Expose Care Gaps for LGBTQ+ People Living With IBD

Teen Boy Grows a Tooth Between Eyelid and Eyebrow

Nurse Alex Pretti's Death and the Symbolism of the Human Body

ACIP Chair Questions Need for Polio Vaccine, and Draws Swift Rebuke

No Pagers Underwater: Doctors on the Healing Power of Diving

Participants Praise Palliative Care Program for the Homeless